000 01057 a2200325 4500
005 20250515024940.0
264 0 _c20061004
008 200610s 0 0 ger d
022 _a0300-8630
024 7 _a10.1055/s-2006-933414
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHartmann, K
245 0 0 _a[Genetic modifiers of homozygous sickle cell disease].
_h[electronic resource]
260 _bKlinische Padiatrie
_c
300 _a170-3 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAnemia, Sickle Cell
_xgenetics
650 0 4 _aChild
650 0 4 _aFetal Hemoglobin
_xgenetics
650 0 4 _aGenetic Therapy
650 0 4 _aHemoglobin, Sickle
_xgenetics
650 0 4 _aHomozygote
650 0 4 _aHumans
650 0 4 _aPrognosis
650 0 4 _aSurvival Rate
650 0 4 _aalpha-Thalassemia
_xgenetics
700 1 _aKulozik, A E
773 0 _tKlinische Padiatrie
_gvol. 218
_gno. 3
_gp. 170-3
856 4 0 _uhttps://doi.org/10.1055/s-2006-933414
_zAvailable from publisher's website
999 _c16288986
_d16288986